Genome-Wide Meta-analysis Identifies Genetic Variants Associated With Glycemic Response to Sulfonylureas. Diabetes Care 2021;44:2673–2682

Adem Y. Dawed; Sook Wah Yee; Kaixin Zhou; Nienke Van Leeuwen; Yanfei Zhang; Moneeza K. Siddiqui; Amy Etheridge; Federico Innocenti; Fei Xu; Josephine H. Li; Joline W. Beulens; Amber A. Van Der Heijden; Roderick C. Slieker; Yu Chuan Chang; Josep M. Mercader; Varinderpal Kaur; John S. Witte; Ming Ta Michael Lee; Yoichiro Kamatani; Yukihide Momozawa; Michiaki Kubo; Colin N.A. Palmer; Jose C. Florez; Monique M. Hedderson; Leen Mt Hart; Kathleen M. Giacomini; Ewan R. Pearson

doi:https://doi.org/10.2337/dci21-0066

Genome-Wide Meta-analysis Identifies Genetic Variants Associated With Glycemic Response to Sulfonylureas. Diabetes Care 2021;44:2673–2682

Adem Y. Dawed, Sook Wah Yee, Kaixin Zhou, Nienke Van Leeuwen, Yanfei Zhang, Moneeza K. Siddiqui, Amy Etheridge, Federico Innocenti, Fei Xu, Josephine H. Li, Joline W. Beulens, Amber A. Van Der Heijden, Roderick C. Slieker, Yu Chuan Chang, Josep M. Mercader, Varinderpal Kaur, John S. Witte, Ming Ta Michael Lee, Yoichiro Kamatani, Yukihide MomozawaMichiaki Kubo, Colin N.A. Palmer, Jose C. Florez, Monique M. Hedderson, Leen Mt Hart, Kathleen M. Giacomini, Ewan R. Pearson

Research output: Contribution to journal › Letter › Academic › peer-review

Original language	English
Pages (from-to)	e82-e83
Journal	Diabetes Care
Volume	45
Issue number	4
DOIs	https://doi.org/10.2337/dci21-0066
Publication status	Published - Apr 2022

Access to Document

https://doi.org/10.2337/dci21-0066

Cite this

Dawed, A. Y., Yee, S. W., Zhou, K., Van Leeuwen, N., Zhang, Y., Siddiqui, M. K., Etheridge, A., Innocenti, F., Xu, F., Li, J. H., Beulens, J. W., Van Der Heijden, A. A., Slieker, R. C., Chang, Y. C., Mercader, J. M., Kaur, V., Witte, J. S., Lee, M. T. M., Kamatani, Y., ... Pearson, E. R. (2022). Genome-Wide Meta-analysis Identifies Genetic Variants Associated With Glycemic Response to Sulfonylureas. Diabetes Care 2021;44:2673–2682. Diabetes Care, 45(4), e82-e83. https://doi.org/10.2337/dci21-0066

@article{3b1ce8b5940e43eca1dafa8c710a6eee,

title = "Genome-Wide Meta-analysis Identifies Genetic Variants Associated With Glycemic Response to Sulfonylureas. Diabetes Care 2021;44:2673–2682",

author = "Dawed, {Adem Y.} and Yee, {Sook Wah} and Kaixin Zhou and {Van Leeuwen}, Nienke and Yanfei Zhang and Siddiqui, {Moneeza K.} and Amy Etheridge and Federico Innocenti and Fei Xu and Li, {Josephine H.} and Beulens, {Joline W.} and {Van Der Heijden}, {Amber A.} and Slieker, {Roderick C.} and Chang, {Yu Chuan} and Mercader, {Josep M.} and Varinderpal Kaur and Witte, {John S.} and Lee, {Ming Ta Michael} and Yoichiro Kamatani and Yukihide Momozawa and Michiaki Kubo and Palmer, {Colin N.A.} and Florez, {Jose C.} and Hedderson, {Monique M.} and {Mt Hart}, Leen and Giacomini, {Kathleen M.} and Pearson, {Ewan R.}",

note = "Funding Information: Funding. The work leading to this publication has received support from the Innovative Medicines Initiative Joint Undertaking under grant agreement no. 115317 (DIRECT), resources of which are composed of financial contribution from the European Union{\textquoteright}s Seventh Framework Programme (FP7/2007-2013) and European Federation of Pharmaceutical Industries (EFPIA) companies{\textquoteright} in-kind contribution. Funding was in part from the National Institutes of Health (NIH), R01-GM117163, to J.C.F., M.M.H., and K.M.G. E.R.P. holds a Wellcome New Investigator Award (102820/Z/13/Z). Funding for the Study to Understand the Genetics of the Acute Response to Metformin and Glipizide in Humans (SUGAR-MGH) was provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH, R01-DK088214. J.H.L. is supported by NIDDK, NIH, T32-DK007028. J.C.F. is supported by NIDDK, NIH, K24-DK110550. The Geisinger MyCode type 2 diabetes project was supported by the Geisinger Health Plan Quality Pilot Fund (principal investigator: M.T.M.L.). Duality of Interest. E.R.P. has received honoraria for speaking from Lilly and Sanofi. J.C.F. has received honoraria for speaking at scientific conferences from Novo Nordisk and for consulting from Goldfinch Bio. No other potential conflicts of interest relevant to this article were reported.",

year = "2022",

month = apr,

doi = "https://doi.org/10.2337/dci21-0066",

language = "English",

volume = "45",

pages = "e82--e83",

journal = "Diabetes Care",

issn = "0149-5992",

publisher = "American Diabetes Association Inc.",

number = "4",

}

Dawed, AY, Yee, SW, Zhou, K, Van Leeuwen, N, Zhang, Y, Siddiqui, MK, Etheridge, A, Innocenti, F, Xu, F, Li, JH, Beulens, JW , Van Der Heijden, AA , Slieker, RC, Chang, YC, Mercader, JM, Kaur, V, Witte, JS, Lee, MTM, Kamatani, Y, Momozawa, Y, Kubo, M, Palmer, CNA, Florez, JC, Hedderson, MM, Mt Hart, L, Giacomini, KM & Pearson, ER 2022, 'Genome-Wide Meta-analysis Identifies Genetic Variants Associated With Glycemic Response to Sulfonylureas. Diabetes Care 2021;44:2673–2682', Diabetes Care, vol. 45, no. 4, pp. e82-e83. https://doi.org/10.2337/dci21-0066

TY - JOUR

T1 - Genome-Wide Meta-analysis Identifies Genetic Variants Associated With Glycemic Response to Sulfonylureas. Diabetes Care 2021;44:2673–2682

AU - Dawed, Adem Y.

AU - Yee, Sook Wah

AU - Zhou, Kaixin

AU - Van Leeuwen, Nienke

AU - Zhang, Yanfei

AU - Siddiqui, Moneeza K.

AU - Etheridge, Amy

AU - Innocenti, Federico

AU - Xu, Fei

AU - Li, Josephine H.

AU - Beulens, Joline W.

AU - Van Der Heijden, Amber A.

AU - Slieker, Roderick C.

AU - Chang, Yu Chuan

AU - Mercader, Josep M.

AU - Kaur, Varinderpal

AU - Witte, John S.

AU - Lee, Ming Ta Michael

AU - Kamatani, Yoichiro

AU - Momozawa, Yukihide

AU - Kubo, Michiaki

AU - Palmer, Colin N.A.

AU - Florez, Jose C.

AU - Hedderson, Monique M.

AU - Mt Hart, Leen

AU - Giacomini, Kathleen M.

AU - Pearson, Ewan R.

N1 - Funding Information: Funding. The work leading to this publication has received support from the Innovative Medicines Initiative Joint Undertaking under grant agreement no. 115317 (DIRECT), resources of which are composed of financial contribution from the European Union’s Seventh Framework Programme (FP7/2007-2013) and European Federation of Pharmaceutical Industries (EFPIA) companies’ in-kind contribution. Funding was in part from the National Institutes of Health (NIH), R01-GM117163, to J.C.F., M.M.H., and K.M.G. E.R.P. holds a Wellcome New Investigator Award (102820/Z/13/Z). Funding for the Study to Understand the Genetics of the Acute Response to Metformin and Glipizide in Humans (SUGAR-MGH) was provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH, R01-DK088214. J.H.L. is supported by NIDDK, NIH, T32-DK007028. J.C.F. is supported by NIDDK, NIH, K24-DK110550. The Geisinger MyCode type 2 diabetes project was supported by the Geisinger Health Plan Quality Pilot Fund (principal investigator: M.T.M.L.). Duality of Interest. E.R.P. has received honoraria for speaking from Lilly and Sanofi. J.C.F. has received honoraria for speaking at scientific conferences from Novo Nordisk and for consulting from Goldfinch Bio. No other potential conflicts of interest relevant to this article were reported.

PY - 2022/4

Y1 - 2022/4

UR - http://www.scopus.com/inward/record.url?scp=85127303738&partnerID=8YFLogxK

U2 - https://doi.org/10.2337/dci21-0066

DO - https://doi.org/10.2337/dci21-0066

M3 - Letter

C2 - 35349657

SN - 0149-5992

VL - 45

SP - e82-e83

JO - Diabetes Care

JF - Diabetes Care

IS - 4

ER -

Genome-Wide Meta-analysis Identifies Genetic Variants Associated With Glycemic Response to Sulfonylureas. Diabetes Care 2021;44:2673–2682

Access to Document

Other files and links

Cite this